BackDaVita Overview
DaVita Inc

DaVita Target Price

See DaVita's analyst price targets ($240) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$185.69

Average Target Price

$235.2526.7% upside

8 analysts in the last 4 months

High: $270 | Low: $215

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07Truist Financial$21515.8% upsideOpen
2026-08-07Oppenheimer$22018.5% upsideOpen
2026-08-07Raymond James$22018.5% upsideOpen
2026-08-05Deutsche BankPito Chickering$26542.7% upsideOpen
2026-08-05BarclaysAndrew Mok$22420.6% upsideOpen
2026-07-14Truist Financial$25034.6% upsideOpen
2026-07-10UBS$27045.4% upsideOpen
2026-07-08Barclays$21817.4% upsideOpen
2026-05-08Truist Financial$20510.4% upsideOpen
2026-05-07BarclaysAndrew Mok$1944.5% upsideOpen
2026-05-06Deutsche BankPito Chickering$22018.5% upsideOpen
2026-02-05Truist Financial$15814.9% downsideOpen
2026-02-04UBS$1902.3% upsideOpen
2026-02-03Barclays$15814.9% downsideOpen
2025-10-30Barclays$14323% downsideOpen
2025-10-14Truist FinancialDavid MacDonald$14024.6% downsideOpen
2025-10-09BarclaysAndrew Mok$14919.8% downsideOpen
2025-08-08Truist FinancialDavid MacDonald$14820.3% downsideOpen
2025-02-21BernsteinLisa Bedell Clive$1840.9% downsideOpen
2024-08-07Bank of America SecuritiesKevin Fischbeck$14521.9% downsideOpen
2024-05-06BarclaysAndrew Mok$15019.2% downsideOpen
2022-10-31BarclaysSarah James$8156.4% downsideOpen
2022-08-19UBSAndrew Mok$11737% downsideOpen
2022-06-28Truist FinancialDavid MacDonald$9051.5% downsideOpen

DaVita (DVA) FAQ

As of the most recent data, DVA shows a target price of $240. Scroll down for historical charts and peer comparison views.

If DaVita moved to the average analyst target of $240, shares would be roughly 26.7% higher than $185.69. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of DaVita's earnings trajectory.

Besides this target price page, Stockcircle has DaVita's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $240) with ownership activity and broader fundamentals.

DaVita's target price is $240; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.